menu
    • menu

    Company profile for Innovent Biologics

    NEW Drugs in Dev: 89
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially prom...
    Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially promising monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, autoimmune, and cardiovascular diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innovent BiologicsChina Flag
    Country
    Country
    China
    Address
    Address
    168 Dongping Street, Suzhou Industrial Park,Jiangsu
    Telephone
    Telephone
    (86)0512-69566088
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://cn.innoventbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/innovent-biologics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innovent's CDMO Approved For Large-Scale Biologics Production
    Innovent's CDMO Approved For Large-Scale Biologics Production

    09 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-delivery/innovents-cdmo-gets-green-light-to-make-biologics-at-large-chinese-plant

    BIOSPACE
    09 Apr 2026
    Share Share
    Innovent Announces 2025 Annual Results And Business Updates
    Innovent Announces 2025 Annual Results And Business Updates

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-announces-2025-annual-results-and-business-updates-302725990.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Innovent Eyes China Approval After Matching Eylea In Phase 3
    Innovent Eyes China Approval After Matching Eylea In Phase 3

    24 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/innovent-sees-path-china-approval-after-eye-disease-drug-matches-eylea-phase-3

    FIERCE BIOTECH
    24 Mar 2026
    Share Share
    Altruist Biologics Introduces Altru-Con For Rapid Biologics
    Altruist Biologics Introduces Altru-Con For Rapid Biologics

    04 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altruist-biologics-launches-altru-con-high-concentration-formulation-platform-to-accelerate-biologics-development-302702704.html

    PR NEWSWIRE
    04 Mar 2026
    Share Share
    Jaypirca Approved in China for R/R CLL and SLL Lymphoma
    Jaypirca Approved in China for R/R CLL and SLL Lymphoma

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jaypirca-pirtobrutinib-approved-in-china-for-the-treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-302699561.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Innovent Starts Phase 3 IBI354 in First-Line HER2+ Breast Cancer
    Innovent Starts Phase 3 IBI354 in First-Line HER2+ Breast Cancer

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-dosed-first-participant-in-phase-3-clinical-study-of-ibi354-novel-her2-adc-for-first-line-treatment-of-her2-positive-breast-cancer-302686402.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search